Live from the NIH registry
Studies recruiting near Naperville right now
Top 25 of 2,356 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
John Stroger Cook County Hospital — Chicago, Illinois (27.5 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loyola University Medical Center (Adults and Pediatrics) — Maywood, Illinois (18.9 mi)
· Sponsor: Pierre Fabre Medicament
Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke
Stroke
N/A
Interventional 70 participants sought
Northwestern University — Chicago, Illinois (27.5 mi)
· Sponsor: Northwestern University
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
University of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
The University of Chicago Medical Center (UCMC) — Chicago, Illinois (27.5 mi)
· Sponsor: Syndax Pharmaceuticals
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: Nationwide Children's Hospital
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Dr. Sudarshan K. Sharma, Ltd. — Hinsdale, Illinois (12.3 mi)
· Sponsor: Kartos Therapeutics, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Advocate Children's Hospital-Oak Lawn — Oak Lawn, Illinois (21.2 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
University Illinois Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: Westat
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
University of Chicago Medical Center — Chicago, Illinois (27.5 mi)
· Sponsor: Genentech, Inc.
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Muscular Atrophy, Spinal
Phase 3
Interventional 30 participants sought
Ann and Robert H Lurie Childrens Hospital of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: Biogen
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Northwestern University — Chicago, Illinois (27.5 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
University of Chicago Medical Center /ID# 278863 — Chicago, Illinois (27.5 mi)
· Sponsor: AbbVie
Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts
Warts, Verruca (Warts)
Phase 2
Interventional 55 participants sought
Rush University Medical Center — Chicago, Illinois (27.5 mi)
· Sponsor: Rush University Medical Center
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Northwestern University — Chicago, Illinois (27.5 mi)
· Sponsor: University of Pennsylvania
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Cancer Treatment Centers of America-Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: American Society of Clinical Oncology
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Prostate Cancer, Prostate Adenocarcinoma
Phase 2
Interventional 90 participants sought
University of Chicago Comprehensive Cancer Center — Chicago, Illinois (27.5 mi)
· Sponsor: University of Chicago
Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures
Anxiety
N/A
Interventional 64 participants sought
Anesthesiology Pain Medicine Center — Chicago, Illinois (27.5 mi)
· Sponsor: Northwestern University
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
University of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: Medstar Health Research Institute
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Northwestern University — Chicago, Illinois (27.5 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Rush University Medical Center — Chicago, Illinois (27.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Horizon Two: HR NDMM (MMRC-100)
High Risk Newly Diagnosed Multiple Myeloma
Phase 2
Interventional 300 participants sought
UChicago Medicine — Chicago, Illinois (27.5 mi)
· Sponsor: Multiple Myeloma Research Consortium
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 Mutation, Low-grade Glioma
Phase 2
Interventional 96 participants sought
Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: University of California, San Francisco
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Re:Cognition Health - Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
University of Chicago Medical Center /ID# 278295 — Chicago, Illinois (27.5 mi)
· Sponsor: AbbVie